Ionis Pharmaceuticals Earnings
NASDAQ: IONSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.20
Ionis Pharmaceuticals earnings summary
Ionis Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-1.20. In its most recent report on Jul 29, 2026 (Q2 2026), IONS posted EPS of $-0.69. Revenue for the quarter was $267.9 million.
Quarterly EPS is down 198.6% from the same quarter a year earlier. Across the last 16 reports, IONS shares moved an average of 3.7% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
IONS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 29, 2026 | — | $-0.69 | — | +9.3% |
| Apr 29, 2026 | — | $-0.56 | — | +0.6% |
| Feb 26, 2026 | — | $-1.41 | — | -8.8% |
| Oct 29, 2025 | — | $-0.80 | — | -1.0% |
| Jul 30, 2025 | — | $0.70 | — | -3.2% |
| Apr 30, 2025 | — | $-0.93 | — | -1.6% |
| Feb 19, 2025 | — | $-0.66 | — | +2.7% |
| Nov 6, 2024 | — | $-0.95 | — | -12.4% |
| Aug 1, 2024 | — | $-0.45 | — | -5.3% |
| May 7, 2024 | — | $-0.98 | — | -4.5% |
| Feb 21, 2024 | — | $-0.06 | — | +0.2% |
| Nov 2, 2023 | — | $-1.03 | — | -1.8% |
| Aug 9, 2023 | — | $-0.60 | — | -3.4% |
| May 3, 2023 | — | $-0.87 | — | -1.9% |
| Feb 22, 2023 | — | $-0.37 | — | +2.5% |
| Nov 9, 2022 | — | $-0.33 | — | -0.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.